Why the study?
Is in vivo platelet activation increased during sleep in patients with OSAS, and does CPAP therapy affect it?
Population
12 patients with untreated obstructive sleep apnea syndrome and 6 healthy volunteer controls
Comparison
Continuous positive airway pressure therapy for… vs Healthy volunteers and baseline untreated state
Design
Case-control
Follow-up
1 night
Authors
Loading...
May link nocturnal platelet activation to OSAS cardiovascular risk; hypothesis-generating for CPAP effects.
Is in vivo platelet activation increased during sleep in patients with OSAS, and does CPAP therapy affect it?
Patients with OSAS exhibit increased in vivo platelet activation during sleep, providing a potential mechanism for their elevated risk of cardiovascular events.
Geiser et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: